S. Moe

发表

Structural Determinants of 4-Chloro-m-cresol Required for Activation of Ryanodine Receptor Type 1

J. Fessenden, P. Allen, A. Jacobson, 2006, Molecular Pharmacology.

Chirality holds the key for potent inhibition of the botulinum neurotoxin serotype a protease.

Karen N. Allen, K. Janda, N. Silvaggi, 2010, Organic letters.

Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin A poisoned mouse neuromuscular junctions

J. McArdle, K. Janda, B. Thyagarajan, 2010, Neuropharmacology.

Botulinum neurotoxin serotype A inhibitors: small-molecule mercaptoacetamide analogs.

R. Stein, Andrew B. Thompson, R. Fredenburg, 2009, Bioorganic & medicinal chemistry.

NPS 1506, A Novel NMDA Receptor Antagonist and Neuroprotectant: Review of Preclinical and Clinical Studies

J. L. Raszkiewicz, A. L. Mueller, E. G. Delmar, 1999, Annals of the New York Academy of Sciences.

Chiral synthesis and pharmacological evaluation of NPS 1407: a potent, stereoselective NMDA receptor antagonist.

J. L. Raszkiewicz, H. White, D. Smith, 2000, Bioorganic & medicinal chemistry letters.

Enantiomers of 11-hydroxy-10-methylaporphine having opposing pharmacological effects at 5-HT1A receptors.

J. P. Long, J. Cannon, S. Moe, 1991, Chirality.

Synthesis of naltrexone-derived delta-opioid antagonists. Role of conformation of the delta address moiety.

P. Portoghese, M. Sultana, A. Takemori, 1994, Journal of medicinal chemistry.

A selective delta 1 opioid receptor agonist derived from oxymorphone. Evidence for separate recognition sites for delta 1 opioid receptor agonists and antagonists.

P. Portoghese, A. Takemori, P S Portoghese, 1993, Journal of medicinal chemistry.

A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding.

P. Portoghese, T. Reisine, K. Yasuda, 1993, The Journal of biological chemistry.

Design, Synthesis, and Biological Evaluation of Spider Toxin (Argiotoxin-636) Analogs as NMDA Receptor Antagonists

J. L. Raszkiewicz, A. L. Mueller, L. Artman, 2004, Pharmaceutical Research.

Synthesis, biological activity, and absolute stereochemical assignment of NPS 1392: a potent and stereoselective NMDA receptor antagonist.

J. Clardy, J. L. Raszkiewicz, D. Smith, 1999, Bioorganic & medicinal chemistry letters.

Preparation and pharmacological evaluation of enantiomers of certain nonoxygenated aporphines: (+)- and (-)-aporphine and (+)- and (-)-10-methylaporphine.

J. P. Long, R. Raghupathi, J. Cannon, 1993, Journal of medicinal chemistry.

Preparation and Pharmacological Evaluation of Enantiomers of Certain Nonoxygenated Aporphines: (+)- and (-)-Aporphine and (+)- and (-)-10- Methylaporphine.

J. P. Long, R. Raghupathi, J. Cannon, 1994 .

NPS 1506, a moderate affinity uncompetitive NMDA receptor antagonist: preclinical summary and clinical experience

J. L. Raszkiewicz, A. L. Mueller, E. G. Delmar, 2000, Amino Acids.